AI

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026

biotech

Confidence boost for AI virtual cells for novel target discovery

Jim Cornall - October 6, 2026

biotech

Anti-fibrotic drug could be repurposed to control cell communication

Jim Cornall - October 6, 2026

biotech

Positive data from oral therapy designed to improve muscle function and body composition

Jim Cornall - October 5, 2026

AI

11 start-ups selected for Irish AI accelerator programme

admin - May 13, 2024

AI

Researcher in Norway increases 6G network capacity

Jim Cornall - May 6, 2024

AI

Boost for security in artificial intelligence and image processing

Jim Cornall - April 29, 2024

AI

AI tool can measure work-related stress

Jim Cornall - March 28, 2024

AI

AI infrastructure survey reveals GPU challenges

Jim Cornall - March 15, 2024

AI

Ten ways AI will shape the next five years

Jim Cornall - January 17, 2024

AI

Oman uses AI to relay real-time election results to citizens

Jim Cornall - November 13, 2023

AI

Can AI change aviation with guaranteed safe landings?

Jim Cornall - October 18, 2023

1...567 Page 6 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026 0

UTR Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 3′UTRMYCN M1-14 (UTRxMYCN M1-14)...

Confidence boost for AI virtual cells for novel target discovery

biotech Jim Cornall - October 6, 2026 0

Anti-fibrotic drug could be repurposed to control cell communication

biotech Jim Cornall - October 6, 2026 0

Positive data from oral therapy designed to improve muscle function and body composition

biotech Jim Cornall - October 5, 2026 0

Pneumonia can reveal undiagnosed blood cancer

biotech Jim Cornall - October 5, 2026 0